EUVIMEDEUVIMED entdecken
Open Access

Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults

Stavros Tsipas, Tamkeen Khan, Fleetwood Loustalot, Klodiana Myftari, Gregory Wozniak

JAMA Network Open · 02.04.2025 · 8 (4) · e252964

DOI: 10.1001/jamanetworkopen.2025.2964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 02.04.2025. Verfasst von Stavros Tsipas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Improving Health Outcomes, American Medical Association, Chicago, Illinois. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This economic evaluation estimates annual total US spending on glucagon-like peptide-1 receptor agonists from 2018 to 2023.

Autor:innen und Institutionen

  • Improving Health Outcomes, American Medical Association, Chicago, Illinois.
  • Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta.

Zitieren

APA

Tsipas, S., Khan, T., Loustalot, F., Myftari, K., & Wozniak, G. (2025). Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults. JAMA Network Open, 8(4), e252964. https://doi.org/10.1001/jamanetworkopen.2025.2964

Vancouver

Tsipas S, Khan T, Loustalot F, Myftari K, Wozniak G. Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults. JAMA Network Open. 2025;8(4):e252964. doi:10.1001/jamanetworkopen.2025.2964

BibTeX
@article{Tsipas2025,
  author = {Tsipas, Stavros and Khan, Tamkeen and Loustalot, Fleetwood and Myftari, Klodiana and Wozniak, Gregory},
  title = {Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {4},
  pages = {e252964},
  doi = {10.1001/jamanetworkopen.2025.2964}
}
Kostenlos starten →